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Abstract: Cocaine is a well known trigger of acute coronary syndromes. Over the last 10 years 
levamisole, a veterinary anthelminthic drug has been increasingly used as an adulterant of cocaine. 
Levamisole was used to treat pediatric nephritic syndrome and rheumatoid arthritis before being 
withdrawn from the market due to its significant toxicity, i.e. hematological complications and 
vasculitis. The major complications of levamisole-adultered cocaine reported up to now are 
hematological and dermatological.  
The case reported here is of a 25 year old man with a history of cocaine abuse who died at home after 
complaining of retrosternal pain. Postmortem CT-angiography, autopsy, and chemical and toxicological 
analyses were performed. An eroded coronary artery plaque was found at the proximal segment of the 
left anterior descending coronary artery. Two myocardial infarct scars were present in the left 
ventricle. Microscopic examination of the coronary artery revealed infiltration of eosinophils into the 
adventitia and intima. Toxicological examination confirmed the presence of cocaine and its metabolites 
in the peripheral blood, and of levamisole in the urine and pericardial fluid.  
Eosinophilic inflammatory coronary artery pathologies have been clinically linked to coronary 
dissection, hypersensitivity coronary syndrome and vasospastic allergic angina. The coronary 
pathology in the presented case could be a complication of levamisole-adultered cocaine use, in which 
an allergic or immune-mediated mechanism might play a role. The rise in cocaine addiction worldwide 
and the increase of levamisole adulterated cocaine highlights the importance of updating our 
knowledge of the effects of adultered cocaine abuse. 
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Acute coronary syndrome after levamisole-adultered cocaine abuse 1 
2 
Abstract 3 
4 
Cocaine is a well known trigger of acute coronary syndromes. Over the last 10 years 5 
levamisole, a veterinary anthelminthic drug has been increasingly used as an adulterant 6 
of cocaine. Levamisole was used to treat pediatric nephritic syndrome and rheumatoid 7 
arthritis before being withdrawn from the market due to its significant toxicity, i.e. 8 
hematological complications and vasculitis. The major complications of levamisole-9 
adultered cocaine reported up to now are hematological and dermatological. 10 
11 
The case reported here is of a 25 year old man with a history of cocaine abuse who 12 
died at home after complaining of retrosternal pain. Postmortem CT-angiography, 13 
autopsy, and chemical and toxicological analyses were performed. An eroded coronary 14 
artery plaque was found at the proximal segment of the left anterior descending 15 
coronary artery. Two myocardial infarct scars were present in the left ventricle. 16 
Microscopic examination of the coronary artery revealed infiltration of eosinophils into 17 
the adventitia and intima. Toxicological examination confirmed the presence of cocaine 18 
and its metabolites in the peripheral blood, and of levamisole in the urine and pericardial 19 
fluid. 20 
21 
Eosinophilic inflammatory coronary artery pathologies have been clinically linked to 22 
coronary dissection, hypersensitivity coronary syndrome and vasospastic allergic 23 
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angina. The coronary pathology in the presented case could be a complication of 24 
levamisole-adultered cocaine use, in which an allergic or immune-mediated mechanism 25 
might play a role. The rise in cocaine addiction worldwide and the increase of 26 
levamisole adulterated cocaine highlights the importance of updating our knowledge of 27 
the effects of adultered cocaine abuse. 28 
29 
30 
Keywords: cocaine, levamisole, eosinophils, coronary artery, sudden death 31 
Introduction 32 
33 
Cocaine greatly influences the cardiovascular system and is a well known trigger of 34 
acute coronary syndromes. The toxic effects of cocaine are related to arterial 35 
vasoconstriction, accelerated atherosclerosis and thrombosis. The reported triggering 36 
pathways include activation of the sympathetic nervous system with a transient increase 37 
in blood pressure, heart rate, plaque activity, and arrhythmias. These changes can lead 38 
to plaque rupture, thrombosis and/or sudden death. 1, 2 39 
40 
Cocaine use is increasing around the world and the drug is frequently altered by 41 
dilution, substitution, contamination and adulteration. 3, 4 Cocaine is adulterated in many 42 
ways, i.e. with local anesthetics and phenacetin. Levamisole was recognized as a 43 
cocaine adulterant in the United States in 2002. Since then the percentage of cocaine 44 
contaminated by levamisole in Europe and the United States rose steadily to reach 45 
approximately 69% in 2009. 5, 6 A clinical study, performed in 2010 in the United States 46 
on hospitalized patients with unexplained agranulocytosis or cutaneous vasculitis, 47 
showed that 83% of patients who tested positive for cocaine also tested positive for 48 
levamisole. 749 
50 
Levamisole is a synthetic imidazothiazole derivate. It is the levo enantiomer of 51 
tetramisole. It has been principally used as a veterinary anthelminthic medication, but 52 
was also used to treat pediatric nephritic syndrome and rheumatoid arthritis before 53 
being withdrawn due to its significant toxicity. 3, 4, 8 Pharmacological effects on the 54 
central nervous system are not completely understood, it was suggested that levamisol 55 
increases the number of D1 dopamine receptors in the brain and potentiate the intense 56 
“high” of cocaine. 4, 6, 9, 10 Sequelae of levamisole administration include leucopenia, 57 
agranulocytosis, leukoencephalopathy, arthritis, thrombotic vasculopathy and vasculitis 58 
(i.e. leucocytoclastic vasculitis and cutaneous necrotizing vasculitis). Levamisole may 59 
provoke hypersensitivity reactions in genetically predisposed individuals 9. The principal 60 
complications reported in cocaine users are hematological (neutropenia) and 61 
dermatological in origin. 6, 11 Recent reports attribute levamisole adultered cocaine use 62 
with a wide variety of clinical manifestations that can be difficult to distinguish from 63 
idiopathic autoimmune rheumatic diseases 8, 9 with a high rate of recurrence (27%) of 64 
symptoms upon re-exposure to cocaine.3  Several authors have suggested that 65 
levamisole-adulterated cocaine might be associated with other severe extracutaneous 66 
manifestations, and that it is clinically important to accurately identify levamisole-67 
induced complications in order to adapt treatment modalities. 4, 5, 8, 12, 13  68 
69 
In this article, we present a case of coronary artery disease in a young cocaine user, 70 
suggesting a new complication which has not yet been reported. 71 
72 
73 
74 
75 
76 
77 
Case Report: 78 
79 
A 25 year old man, who was known to be a cocaine addict, died suddenly at home after 80 
complaining of retrosternal pain. The electrocardiogram performed by the rescue team 81 
showed ventricular fibrillation. A year prior to death the patient had presented to the 82 
emergency room with a Q-wave myocardial infarction. His blood lipids levels were 83 
normal. The patient refused coronarography and did not follow the prescribed treatment 84 
plan. He complained of pins and needles in the left arm, especially in the morning, and 85 
of retrosternal pain after an effort. 86 
87 
A complete postmortem examination was performed the day after he died. 88 
89 
External examination: The decedent was of average build and nutrition. He weighed 52 90 
kg and had a BMI of 19. There were signs of resuscitation attempts (sternal fracture, 91 
and defibrillator and injection marks). 92 
93 
Post-mortem radiology: native (unenhanced) CT scan and multi-phase post-mortem CT 94 
angiography (MPMCTA) 14 were performed by a trained forensic radiographer 15 on an 95 
8-row CT-unit (CT LightSpeed 8, GE Healthcare, Milwaukee, WI, USA) using the 96 
following scan parameters: field of view: 50 cm, slice thickness: 1.25 mm, interval: 1mm, 97 
120 kV, 280 mA (modulated), tube rotation: 0.8 sec, pitch: 0.875. Peripheral blood, 98 
cerebrospinal and vitreous fluids, and hair samples for toxicological analysis were 99 
collected according to standard autopsy protocol prior to the injection of the contrast 100 
agent. Samples of bile and urine were obtained under CT-guidance as described by 101 
Schneider et al. 16 MPMCTA, was performed using a Virtangio® perfusion device and 102 
the oily contrast agent Angiofil® (Fumedica AG, Switzerland) mixed with paraffin oil 103 
(paraffinum liquidum, obtained in the local pharmacy) at a ratio of 1:6.  Cannulation was 104 
performed in the left inguinal region. Angiography was performed following the standard 105 
protocol of MPMCTA of Grabherr et al. 14 Scan parameters of the arterial phase were: 106 
field of view: 50 cm, slice thickness: 1.25 mm, interval: 0.6 mm, 120 kV, 280 mA 107 
(modulated), tube rotation: 0.8 sec, pitch: 0.875. For the venous and dynamic phases of 108 
MPMCTA, the following scan parameters were used: field of view: 50 cm, slice 109 
thickness: 2.5 mm, interval: 2 mm, 120 kV, 280 mA (modulated), tube rotation: 0.8 sec, 110 
pitch: 0.875. 111 
112 
Image interpretation was performed by two board certified radiologists; one specialized 113 
in vascular radiology the other in neuro-radiology, along with one board certified 114 
forensic pathologist trained in forensic imaging. A post-mortem radiological report was 115 
completed, describing all of the findings observed in native CT and in each phase of 116 
MPMCTA. Radiological findings included pulmonary edema and pleural effusion (Fig 117 
1a), which was already visible in the unenhanced CT-scan. The arterial phase of 118 
PMCTA revealed pathological enhancement of the myocardium of the left ventricle and 119 
septum (Fig. 1a), as well as a luminal stenosis of the proximal portion of the left anterior 120 
descending artery (Fig 1b). 121 
122 
123 
Forensic Autopsy: The heart weighted 330 grams (predicted  heart weight according to 124 
Kitzman et al 213-371 grams17 , and for the local population 207.5-378 grams 125 
http://calc.chuv.ch/Heartweight). The ventricles were dilated; the left ventricle thickness 126 
was 1.4 cm and the cardiac valves were unremarkable. A small eroded plaque was 127 
found in the proximal portion of the left anterior descending artery (LAD) (Fig 1c). There 128 
were two fibrous scars of healed infarction in the left ventricular myocardium (Fig 1d): a 129 
transmural scar in the anterolateral wall and a subendocardiac scar in the anterior part 130 
of the ventricular septum. Pleural effusion (250 ml on the right and 100 ml on the left) 131 
and pulmonary edema were present. The other organs were normal. 132 
133 
Histological analysis: Histological examinations were performed on the brain, lungs, 134 
kidneys, liver, myocardium and the proximal segment of the LAD using standard H&E 135 
and trichrome staining. Myocardial examination revealed fibrous tissue in the 136 
anterolateral wall and in the anterior septum. A few contraction bands were observed in 137 
the anterior wall. There was no eosinophilic infiltration in the myocardium and the 138 
intramural coronary arteries were free from inflammation. Microscopic examination of 139 
the proximal portion of the LAD artery showed fibrous thickening of the intima and an 140 
infiltration of numerous eosinophils into the adventitia and intima (Fig 2 a-b). A small 141 
amount of thrombotic material adhering to the eroded plaque was detected (Fig 2 c-d). 142 
Fibrinoid necrosis and granulomatous changes were not found in the inflammatory 143 
areas. No signs of vasculitis were observed in the other organs. 144 
145 
Toxicological analysis: The toxicological analyses of femoral blood obtained before 146 
radiological examination and performed by GC-MS revealed the presence of cocaine 147 
(340µg/L) and its metabolites (benzoylecgonine 610 µg/L, methylecgonine 210 µg/L). 148 
Screening analyses detected levamisole in the urine and pericardial fluid, and 149 
phenacetin in the pericardial fluid. No alcohol was detected. Cocaine was detected in 150 
the hair samples (9 ng/mg); the maximal hair length was 2 cm. 151 
152 
Postmortem laboratory investigations demonstrated a normal CRP level (less than 2 153 
mg/L), elevated levels of troponin I (0.28 µg/L; normal < 0.04) and NT-proBNP (211 154 
ng/L; normal < 115 ng/L) and tryptase at its upper limit (12.1 µg/L, normal < 13.5 µg/L). 155 
156 
157 
Discussion 158 
159 
An acute coronary event can result from numerous conditions, for example rising 160 
catecholamine and cortisol levels, exposure to toxins and drug intake. 18 Cocaine is a 161 
well known trigger of acute coronary syndromes 2, 19, 20 and vasculitis is a well-described 162 
complication of cocaine use. The presence of increased numbers of adventitial mast 163 
cells has been reported in cocaine abusers 21, as well as eosinophilic myocarditis. 22 164 
Eosinophilic coronary inflammation, however, has not been previously reported in 165 
cocaine users. Churg-Strauss vasculitis with biopsy-proved eosinophilic infiltrates in 166 
small arteries and venules has been reported in one case of an adult cocaine user by 167 
Orriols et al but toxicological analyses were not performed. 23  168 
169 
170 
Coronary vasculitis can occur as an isolated entity or as a manifestation of a systemic 171 
172 
disease, i.e. Churg–Strauss syndrome, systemic lupus erythematosus, rheumatoid 
arthritis, ankylosing spondylitis or Behçet’s disease.24-26 Mixed inflammatory infiltrate, 
173 
rich in eosinophils was described in many cases of coronary artery dissection thought 174 
without exact understanding of the mechanism27, 28 except while occurring as a175 
consequence of instrumentation of the coronary arteries. Coronary artery dissection 176 
was largely described in young women, with many cases occurring in the early 177 
postpartum period 29. Eosinophilic coronary periarteritis was recently reported by 178 
Kajihara et al as a new type of coronary arteritis, in which the patients present with 179 
Prinzmetal’s vasospastic angina, eosinophilic inflammation limited to the adventitia 180 
(primarily in the LAD artery) and the absence of other types of vasculitis. An allergic or 181 
immune-mediated mechanism was suggested to play an important role in the presence 182 
of eosinophilic inflammation around the vasa-vasorum of the coronary arteries. 30 A 183 
similar case was presented by Takira et al, who suggested that marked inflammation 184 
with eosinophils in the adventitia causes intimal thickening and vasospasm of the 185 
coronary artery via cytokines and lipid mediators 31. Eosinophils and hypersensitivity 186 
coronary syndrome (aka Kounis syndrome) has also been described as three clinical 187 
188 variants: vasospastic allergic angina, allergic myocardial infarction and stent thrombosis 
with the occluding thrombus infiltrated by eosinophils and/or mast cells. 32, 33 It is fairly 189 
common to observe macrophages in areas of ruptured plaques, but only recently has 190 
been suggested that eosinophils might play an important role in the development of 191 
coronary atherosclerosis.34, 35 These mechanisms may be involved in the present case 192 
considering the eosinophilic infiltrations seen on histological examination.  The tryptase 193 
measurement, useful in the post-mortem diagnosis of anaphylaxis and anaphylactoid 194 
reactions as its blood level rise from a few minutes up to several hours after mast cell 195 
degranulation 36, was in the “normal” range. In our opinion the postmortem tryptase level 196 
in this case does not exclude a hypersensitivity coronary syndrome considering that 197 
tryptase level is not consistently elevated in drug-induced anaphylaxis. 37, 38The 198 
toxicological analyses confirmed both chronic and acute cocaine abuse, as well as the 199 
presence of levamisole. Levamisole is a highly toxic substance known to provoke 200 
hypersensitivity reactions. Levamisole increases T-cell activation and proliferation, 201 
neutrophil mobility, adherence, and chemotaxis and increases the formation of antibody 202 
to antigen complexes. 7, 9, 39 Phenacetin, found in the pericardial fluid, is another 203 
recognized cocaine adulterant, but its reported health consequences have been linked 204 
to renal failure and carcinogenicity.4 In our opinion, the eosinophilic inflammation of the 205 
coronary artery and the acute coronary syndrome could be related at least partly to 206 
levamisole use although it is impossible to separate the complications resulting from 207 
cocaine and/or levamisole use. 208 
209 
210 
It is very important to document and report all possible manifestations of adultered 211 
cocaine abuse in order to avoid any clinical misdiagnoses and to prevent unnecessary 212 
treatments with potentially toxic therapies. 4, 5, 8, 12 This is the first post-mortem case 213 
report of eosinophilic inflammatory coronary artery pathology following levamisole 214 
adultered cocaine abuse, complete with post-mortem imaging and toxicological 215 
analyses. The coronary pathology and sudden death in this case can be considered as 216 
possible levamisole-adultered induced complication, which have not been previously 217 
described although it is impossible to prove that levamisol played any role in the 218 
disease process. The rise in cocaine addiction worldwide and the increased use of 219 
levamisole adulterated cocaine underscores the clinical and public health needs to fully 220 
understand the effects of adultered cocaine abuse on the cardiovascular system. 221 
222 
223 
224 
225 
226 
227 
228 
Figures 229 
230 
Fig.1  Axial image of the arterial phase of MPMCTA (a) showing pulmonary edema with 231 
bilateral pleural effusion (yellow arrows in a), as well as pathological 232 
enhancement of the myocardium of the left ventricle and septum (red arrows in a) 233 
related to an old infarct. 3D-reconstruction of the coronary arteries (b) obtained 234 
after the arterial phase of MPMCA clearly demonstrates a perfusion problem of 235 
the proximal segment of the LAD artery, corresponding to a luminal stenosis 236 
(arrow in b). Autopsy revealed a small eroded plaque in the proximal portion of 237 
the LAD (arrow in c) and healed transmural infarcts in the antero-lateral wall of 238 
the left ventricle (white arrow in d) and in the anterior part of the septum (black 239 
arrow in d) 240 
241 
Fig. 2 Histological examination of the proximal LAD artery showing eosinophilic 242 
infiltrates within the adventitia (a), and the intima (b) and the initial thrombotic 243 
phenomena (b, c, d) Hematoxyline & Eosin stain 244 
245 
246 
247 
248 
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